Xcout Intel
Enthera competitors & alternatives
The 12 closest competitors and alternatives to Enthera among biotechnology companies — ranked by similarity to what Enthera actually does, not by market-cap band.
Subscribe to see Enthera’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Enthera
Enthera is a clinical-stage biopharmaceutical company founded in 2016 and headquartered in Milan, Italy. The company focuses on developing first-in-class therapeutics for auto-immune disorders and is backed by investors such as Sofinnova Partners and BiovelocITA.
Enthera at a glance
Enthera is a biotechnology company headquartered in Italy. It has raised at least $33M across the 2 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round, Series A, closed in January 2021. Xcout tracks 5 named people at Enthera, including Lisa Maria Olson, PhD (Chief Executive Officer/Director).
Enthera leadership
- Lisa Maria Olson, PhDChief Executive Officer/Director
- Silvano SpinelliChairman Enthera and BiovelocITA
- Anja HarmeierDirector at Enthera, Head of Roche Venture Fund
- Kazumi ShiosakiIndependent Director at Enthera and Chair of the Business Development Committee
- Graziano SeghezziDirector at Enthera, Managing Partner at Sofinnova Partners
Enthera funding rounds
At least $33M raised across the 2 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | Undisclosed | 8 named | |
| Series A | $33M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Enthera competitors
Ranked by semantic similarity — how close each company is to Enthera by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Mysthera Therapeutics AG is a biotechnology company headquartered in Basel, Switzerland, focused on developing first-in-class, oral therapeutics to treat inflammation-driven and related diseases.
Similar biotechnology company
Polyneuron Pharmaceuticals is a venture-backed biotech and life sciences company headquartered in Basel, Switzerland. Founded in 2014, the company is pioneering a novel therapeutic approach for the effective and safe treatment of antibody-mediated autoimmune diseases.
Similar biotechnology company
AbolerIS Pharma is a pre-clinical stage biotech company founded in Nantes, France, specializing in the development of innovative immunomodulators and advanced biopharmaceuticals for autoimmune conditions.
Biotech
Electra Therapeutics is a biopharmaceutical company focused on developing first-in-class antibody therapies targeting signal regulatory proteins (SIRP) for immunological and oncological diseases.
Biotech
Cyxone AB is a clinical-stage biotechnology company headquartered in Malmö, Sweden. It focuses on developing a new generation of disease-modifying therapies for autoimmune and autoinflammatory diseases.
Similar biotechnology company
Viela Bio, Inc. is a clinical-stage biotechnology company headquartered in Gaithersburg, Maryland, dedicated to the discovery, development, and commercialization of novel therapies for autoimmune and severe inflammatory diseases.
Similar biotechnology company
AviSia Therapeutics is a clinical-stage biotechnology company headquartered in Amsterdam, Netherlands, pioneering antigen-specific immunotherapies for autoimmune diseases. Established as a spin-off, the company develops targeted treatments to reprogram immune responses.
Biotech
Ditto Biosciences is a company headquartered in San Francisco, US, that focuses on drug discovery. The company is involved in identifying proteins that could lead to new drugs for patients with autoimmune diseases.
Similar biotechnology company
SemaThera Inc. is a biotechnology company headquartered in Montreal, Canada, focused on developing novel therapeutics and biologic treatments.
Similar biotechnology company
Artax Biopharma, Inc. is a clinical-stage biotechnology company founded in 2013 and headquartered in Cambridge, Massachusetts. The company is focused on transforming the treatment of immune system diseases and recently raised $8 million ahead of a Phase 2a clinical trial.
Biotech
Neovacs is a French biotechnology company that develops active immunotherapies using its proprietary Kinoïde technology platform to treat conditions such as lupus and allergies. Additionally, the company operates an investment activity, funding innovative biotechnology and medical technology companies.
Similar biotechnology company
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for inflammatory and autoimmune diseases. Headquartered in California, the company advances a robust clinical pipeline and operates as a publicly traded enterprise.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Enthera and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Entheraand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →